Coming to grips with integrin binding to ligands: Opinion

Current Opinion in Cell Biology

Volumn 14, Issue 5, 2002, Pages 641-652

  Arnaout, M Amin ^a   Goodman, Simon L ^b   Xiong, Jian Ping ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b MERCK KGAA   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ARGINYLGLYCYLASPARTIC ACID; ASPARTIC ACID; CELL SURFACE RECEPTOR; DIVALENT CATION; GLUTAMIC ACID; INTEGRIN RECEPTOR; LIGAND; VASCULAR CELL ADHESION MOLECULE 1;

AMINO ACID SEQUENCE; ANIMAL CELL; BINDING AFFINITY; BINDING SITE; CELL FUNCTION; CELL SURVIVAL; CONFORMATION; CRYSTAL STRUCTURE; HUMAN; HUMAN CELL; MOLECULAR MODEL; MOLECULAR RECOGNITION; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN MOTIF; PROTEIN PROTEIN INTERACTION; PROTEIN STRUCTURE; REGULATORY MECHANISM; REVIEW;

ANIMALIA;

EID: 0036775035     PISSN: 09550674     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0955-0674(02)00371-X     Document Type: Review

References (112)

1. Hynes R.O. Integrins: versatility, modulation and signaling in cell adhesion. Cell. 69:1992;11-26.
2. Yamada K.M., Geiger B. Molecular interactions in cell adhesion complexes. Curr Opin Cell Biol. 9:1997;76-85.
3. Humphries M.J. Integrin structure. Biochem Soc Trans. 28:2000;311-339.
4. Ziober B.L., Vu M.P., Waleh N., Crawford J., Lin C.S., Kramer R.H. Alternative extracellular and cytoplasmic domains of the integrin alpha 7 subunit are differentially expressed during development. J Biol Chem. 268:1993;26773-26783.
5. Jenkins A.L., Nannizzi-Alaimo L., Silver D., Sellers J.R., Ginsberg M.H., Law D.A., Phillips D.R. Tyrosine phosphorylation of the beta3 cytoplasmic domain mediates integrin-cytoskeletal interactions. J Biol Chem. 273:1998;13878-13885.
6. Cowan K.J., Law D.A., Phillips D.R. Identification of Shc as the primary protein binding to the tyrosine-phosphorylated beta 3 subunit of alpha IIb beta 3 during outside-in integrin platelet signaling. J Biol Chem. 275:2000;36423-36429.
7. Fagerholm S., Morrice N., Gahmberg C.G., Cohen P. Phosphorylation of the cytoplasmic domain of the integrin CD18 chain by protein kinase C isoforms in leukocytes. J Biol Chem. 277:2002;1728-1738.
8. Pierschbacher M.D., Ruoslahti E. Cell attachment activity of fibronectin can be duplicated by small synthetic fragments of the molecule. Nature. 309:1984;30-33.
9. Plow E.F., Haas T.A., Zhang L., Loftus J., Smith J.W. Ligand binding to integrins. J Biol Chem. 275:2000;21785-21788.
10. Nemerow G.R., Cheresh D.A. Herpesvirus hijacks an integrin. Nat Cell Biol. 4:2002;E69-71.
11. Isberg R.R., Tran V.N.G. Binding and internalization of microorganisms by integrin receptors. Trends Microbiol. 2:1994;10-14.
12. Reddy V.B., Kounga K., Mariano F., Lerner E.A. Chrysoptin is a potent glycoprotein IIb/IIIa fibrinogen receptor antagonist present in salivary gland extracts of the deerfly. J Biol Chem. 275:2000;15861-15867.
13. Gould R.J., Polokoff M.A., Friedman P.A., Huang T.F., Holt J.C., Cook J.J., Niewiarowski S. Disintegrins: a family of integrin inhibitory proteins from viper venoms. Proc Soc Exp Biol Med. 195:1990;168-171.
14. Rieu P., Ueda T., Haruta I., Sharma C.P., Arnaout M.A. The A-domain of β2 integrin CR3 (CD11b/CD18) is a receptor for the hookworm-derived neutrophil adhesion inhibitor NIF. J Cell Biol. 127:1994;2081-2091.
15. Jones E.L., Harlos K., Bottomley M.J., Robinson R.C., Driscoll P.C., Edwards R.M., Clements J.M., Dudgeon T.J., Stuart D.I. Crystal structure of an integrin-binding fragment of vascular cell adhesion molecule-1 at 1.8 Å resolution. Nature. 373:1995;539-544.
16. Leahy D.J., Aukhil I., Erickson H.P. 2.0 Å crystal structure of a four-domain segment of human fibronectin encompassing the RGD loop and synergy region. Cell. 84:1996;155-164.
17. Bella J., Kolatkar P.R., Marlor C.W., Greve J.M., Rossmann M.G. The structure of the two amino-terminal domains of human ICAM-1 suggests how it functions as a rhinovirus receptor and as an LFA-1 integrin ligand. Proc Natl Acad Sci USA. 95:1998;4140-4145.
18. Casasnovas J.M., Stehle T., Liu J.H., Wang J.H., Springer T.A. A dimeric crystal structure for the N-terminal two domains of intercellular adhesion molecule-1. Proc Natl Acad Sci USA. 95:1998;4134-4139.
19. Ruoslahti E. RGD and other recognition sequences for integrins. Annu Rev Cell Dev Biol. 12:1996;697-715.
20. Michishita M., Videm V., Arnaout M.A. A novel divalent cation-binding site in the A domain of the β2 integrin CR3 (CD11b/CD18) is essential for ligand binding. Cell. 72:1993;857-867.
21. Lee J.-O., Rieu P., Arnaout M.A., Liddington R. Crystal structure of the A-domain from the α-subunit of β2 integrin complement receptor type 3 (CR3, CD11b/CD18). Cell. 80:1995;631-638.
22. Xiong J.P., Stehle T., Diefenbach B., Zhang R., Dunker R., Scott D.L., Joachimiak A., Goodman S.L., Arnaout M.A. Crystal structure of the extracellular segment of integrin alpha Vbeta3. Science. 294:2001;339-345. This paper provides the first crystal structure of the extracellular segment of an integrin. This work provides the basis of future investigations into structure-activity relationships in all integrins.
23. Xiong J.P., Stehle T., Zhang R., Joachimiak A., Frech M., Goodman S.L., Arnaout M.A. Crystal structure of the extracellular segment of integrin aVb3 in complex with an Arg-Gly-Asp ligand. Science. 296:2002;151-155. In this study, the authors report the first atomic structure an integrin in complex with a peptide ligand (RGD, in this case). The authors provide a basis for the absolute dependence of αVβ3 on the RGD sequence for recognition of all its ligands.
24. 2+-dependent binding of collagen by the integrin alpha 2 beta 1 in human platelets. J Biol Chem. 275:2000;24560-24564.
25. Hu D.D., Barbas C.F., Smith J.W. An allosteric Ca2+ binding site on the beta3-integrins that regulates the dissociation rate for RGD ligands. J Biol Chem. 271:1996;21745-21751.
26. Phillips D.R., Baughan A.K. Fibrinogen binding to human platelet plasma membranes. Identification of two steps requiring divalent cations. J Biol Chem. 258:1983;10240-10246.
27. 2+. J Biol Chem. 270:1995;26270-26277.
28. Brekken R.A., Sage E.H. SPARC, a matricellular protein: at the crossroads of cell-matrix. Matrix Biol. 19:2000;569-580.
29. Detmers P.A., Wright S.D., Olsen E., Kimball B., Cohn Z.A. Aggregation of complement receptors on human neutrophils in the absence of ligand. J Cell Biol. 105:1987;1137-1145.
30. Faull R.J., Kovach N.L., Harlan J.M., Ginsberg M.H. Stimulation of integrin-mediated adhesion of T lymphocytes and monocytes: two mechanisms with divergent biological consequences. J Exp Med. 179:1994;1307-1316.
31. 2+ modulates leukocyte function-associated antigen-1 cell surface distribution on T lymphocytes and consequently affects cell adhesion. J Cell Biol. 124:1994;1061-1070.
32. Weber C., Kitayama J., Springer T.A. Differential regulation of beta 1 and beta 2 integrin avidity by chemoattractants in eosinophils. Proc Natl Acad Sci USA. 93:1996;10939-10944.
33. 2+-dependent protease, calpain. J Cell Biol. 140:1998;699-707.
34. Grabovsky V., Feigelson S., Chen C., Bleijs D.A., Peled A., Cinamon G., Baleux F., Arenzana-Seisdedos F., Lapidot T., van Kooyk Y., et al. Subsecond induction of alpha4 integrin clustering by immobilized chemokines stimulates leukocyte tethering and rolling on endothelial vascular cell adhesion molecule 1 under flow conditions. J Exp Med. 192:2000;495-506.
35. Feigelson S.W., Grabovsky V., Winter E., Chen L.L., Pepinsky R.B., Yednock T., Yablonski D., Lobb R., Alon R. The Src kinase p56(Lck) up-regulates VLA-4 integrin affinity. Implications for rapid spontaneous and chemokine-triggered T cell adhesion to VCAM-1 and fibronectin. J Biol Chem. 276:2001;13891-13901. Provides data that high affinity is essential for firm adhesion, and incriminate p56(Lck) as a key mediator of this effect in lymphocytes. This work follows previous work by this group suggesting that avidity but not affinity mediates rolling and tethering of lymphocytes [34] .
36. Peerschke E.I. Bound fibrinogen distribution on stimulated platelets. Examination by confocal scanning laser microscopy. Am J Pathol. 147:1995;678-687.
37. Kucik D.F., Dustin M.L., Miller J.M., Brown E.J. Adhesion-activating phorbol ester increases the mobility of leukocyte integrin LFA-1 in cultured lymphocytes. J Clin Invest. 97:1996;2139-2144.
38. Litvinov R.I., Shuman H., Bennett J.S., Weisel J.W. Binding strength and activation state of single fibrinogen-integrin pairs on living cells. Proc Natl Acad Sci USA. 99:2002;7426-7431. This interesting study evaluates integrin activation states using laser tweezer-based methods that measure the rupture forces required to separate single ligand-receptor pairs. The rupture forces of individual fibrinogen molecules and either purified or platelet-bound αIIbβ3 were 60-150 pN with a peak yield strength of 80-100 pN. Platelet stimulation enhanced accessibility but not affinity of single αIIbβ3 molecules indicating that αIIbβ3 activation is an all-or-none phenomenon, consistent with our model in αA integrins [53] .
39. Hughes P.E., Diaz-Gonzalez F., Leong L., Wu C., McDonald J.A., Shattil S.J., Ginsberg M.H. Breaking the integrin hinge. J Biol Chem. 271:1996;6571-6574.
40. Arnaout MA: Integrin structure: new twists and turns in dynamic cell adhesion. Immunol Rev 2002, in press.
41. Calvete J.J., Arias J., Alvarez M.V., Lopez M.M., Henschen A., Gonzalez-Rodriguez J. Further studies on the topography of human platelet glycoprotein IIb. Localization of monoclonal antibody epitopes and the putative glycoprotein IIa- and fibrinogen-binding regions. Biochem J. 273:1991;767-775.
42. Sims P.J., Ginsberg M.H., Plow E.F., Shattil S.J. Effect of platelet activation on the conformation of the plasma membrane glycoprotein IIb-IIIa complex. J Biol Chem. 266:1991;7345-7352.
43. Loster K., Hofmann W., Calvete J.J., Reutter W. Chemical cross-linking detects different conformational arrangements of platelet integrin alpha IIb beta III (γπIIb/IIIa). Biochem Biophys Res Commun. 229:1996;454-459.
44. Tsuchida J., Ueki S., Takada Y., Saito Y., Takagi J. The 'ligand-induced conformational change' of alpha 5 beta 1 integrin. Relocation of alpha 5 subunit to uncover the beta 1 stalk region. J Cell Sci. 111:1998;1759-1766.
45. Mould A.P., Garratt A.N., Puzon-McLaughlin W., Takada Y., Humphries M.J. Regulation of integrin function: evidence that bivalent-cation-induced conformational changes lead to the unmasking of ligand-binding sites within integrin alpha5 beta1. Biochem J. 331:1998;821-828.
46. Emsley J., Knight C.G., Farndale R.W., Barnes M.J., Liddington R.C. Structural basis of collagen recognition by integrin α2β1. Cell. 100:2000;47-56.
47. Xiong J.P., Li R., Essafi M., Stehle T., Arnaout M.A. An isoleucine-based allosteric switch controls affinity and shape shifting in integrin CD11b A-domain. J Biol Chem. 275:2000;38762-38767.
48. Yan B., Hu D.D., Knowles S.K., Smith J.W. Probing chemical and conformational differences in the resting and active conformers of platelet integrin alpha(IIb)beta(3). J Biol Chem. 275:2000;7249-7260.
49. Hantgan R.R., Paumi C., Rocco M., Weisel J.W. Effects of ligand-mimetic peptides Arg-Gly-Asp-X (X = Phe, Trp, Ser) on alphaIIbbeta3 integrin conformation and oligomerization. Biochemistry. 38:1999;14461-14474.
50. Lam S.C. Isolation and characterization of a chymotryptic fragment of platelet glycoprotein IIb-IIIa retaining Arg-Gly-Asp binding activity. J Biol Chem. 267:1992;5649-5655.
51. Weisel J.W., Nagaswami C., Vilaire G., Bennett J.S. Examination of the platelet membrane glycoprotein IIb-IIIa complex and its interaction with fibrinogen and other ligands by electron microscopy. J Biol Chem. 267:1992;16637-16643.
52. Qu A., Leahy D.J. Crystal structure of the I-domain from the CD11a/CD18 (LFA-1, αLβ2) integrin. Proc Natl Acad Sci USA. 92:1995;10277-10281.
53. 2+-complexed crystal structures. J Cell Biol. 143:1998;1523-1534.
54. Tuckwell D.S., Humphries M.J., Brass A. A secondary structure model of the integrin alpha subunit N-terminal domain based on analysis of multiple alignments. Cell Adhes Commun. 2:1994;385-402.
55. Springer T.A. Folding of the N-terminal, ligand binding region of integrin a-subunits into a β-propeller. Proc Natl Acad Sci USA. 94:1997;65-72.
56. Irie A., Kamata T., Puzon-McLaughlin W., Takada Y. Critical amino acid residues for ligand binding are clustered in a predicted β-turn of the third N-terminal repeat in the integrin α4 and α5 subunits. EMBO J. 14:1995;5550-5556.
57. Loftus J.C., Halloran C.E., Ginsberg M.H., Feigen L.P., Zablocki J.A., Smith J.W. The amino-terminal one-third of alpha IIb defines the ligand recognition specificity of integrin alpha IIb beta 3. J Biol Chem. 271:1996;2033-2039.
58. Mould A.P., Burrows L., Humphries M.J. Identification of amino acid residues that form part of the ligand-binding pocket of integrin alpha5 beta1. J Biol Chem. 273:1998;25664-25672.
59. Kamata T., Tieu K.K., Tarui T., Puzon-McLaughlin W., Hogg N., Takada Y. The role of the CPNKEKEC sequence in the beta(2) subunit I domain in regulation of integrin alpha(L)beta(2) (LFA-1). J Immunol. 168:2002;2296-2301.
60. Charo I.F., Nannizzi L., Phillips D.R., Hsu M.A., Scarborough R.M. Inhibition of fibrinogen binding to GPIIb-IIIa by a GPIIIa peptide. J Biol Chem. 266:1991;1415-1421.
61. Goodman T.G., Bajt M.L. Identifying the putative metal ion-dependent adhesion site in the beta2 (CD18) subunit required for alphaLbeta2 and alphaMbeta2 ligand interactions. J Biol Chem. 271:1996;23729-23736.
62. Puzon-McLaughlin W., Takada Y. Critical residues for ligand binding in an I domain-like structure of the integrin β1 subunit. J Biol Chem. 271:1996;20438-20443.
63. Lu C., Shimaoka M., Zang Q., Takagi J., Springer T.A. Locking in alternate conformations of the integrin alpha Lbeta 2 I domain with disulfide bonds reveals functional relationships among integrin domains. Proc Natl Acad Sci USA. 98:2001;2393-2398.
64. D'Souza S.E., Ginsberg M.H., Burke T.A., Lam S.C.-T., Plow E.F. Localization of an Arg-Gly-Asp recognition site within an integrin adhesion receptor. Science. 242:1988;91-93.
65. Smith J.W., Ruggeri Z.M., Kunicki T.J., Cheresh D.A. Interaction of integrins alpha v beta 3 and glycoprotein IIb-IIIa with fibrinogen. Differential peptide recognition accounts for distinct binding sites. J Biol Chem. 265:1990;12267-12271.
66. Lin E.C., Ratnikov B.I., Tsai P.M., Gonzalez E.R., McDonald S., Pelletier A.J., Smith J.W. Evidence that the integrin beta3 and beta5 subunits contain a metal ion-dependent adhesion site-like motif but lack an I domain. J Biol Chem. 272:1997;14236-14243.
67. Tidswell M., Pachynski R., Wu S.W., Qiu S.Q., Dunham E., Cochran N., Briskin M.J., Kilshaw P.J., Lazarovits A.I., Andrew D.P., et al. Structure-function analysis of the integrin beta 7 subunit: identification of domains involved in adhesion to MAdCAM-1. J Immunol. 159:1997;1497-1505.
68. Chen L.L., Lobb R.R., Cuervo J.H., Lin K., Adams S.P., Pepinsky R.B. Identification of ligand binding sites on integrin alpha4beta1 through chemical cross-linking. Biochemistry. 37:1998;8743-8753.
69. Zhang X.P., Puzon-McLaughlin W., Irie A., Kovach N., Prokopishyn N.L., Laferte S., Takeuchi K., Tsuji T., Takada Y. Alpha 3 beta 1 adhesion to laminin-5 and invasin: critical and differential role of integrin residues clustered at the boundary between alpha 3 N-terminal repeats 2 and 3. Biochemistry. 38:1999;14424-14431.
70. Mould A.P., Askari J.A., Humphries M.J. Molecular basis of ligand recognition by integrin alpha 5beta 1. I. Specificity of ligand binding is determined by amino acid sequences in the second and third NH2-terminal repeats of the alpha subunit. J Biol Chem. 275:2000;20324-20336.
71. Takagi J., Kamata T., Meredith J., Puzon-McLaughlin W., Takada Y. Changing ligand specificities of alphavbeta1 and alphavbeta3 integrins by swapping a short diverse sequence of the beta subunit. J Biol Chem. 272:1997;19794-19800.
72. Plow E.F., Srouji A.H., Meyer D., Marguerie G., Ginsberg M.H. Evidence that three adhesive proteins interact with a common recognition site on activated platelets. J Biol Chem. 259:1984;5388-5391.
73. Lam S.C., Plow E.F., Smith M.A., Andrieux A., Ryckwaert J.J. Evidence that arginyl-glycyl-aspartate peptides and fibrinogen γ chain peptides share a common binding site on platelets. J Biol Chem. 26:1987;947-950.
74. Bennett J.S., Shattil S.J., Power J.W., Gartner T.K. Interaction of fibrinogen with its platelet receptor. Differential effects of alpha and gamma chain fibrinogen peptides on the glycoprotein IIb-IIIa complex. J Biol Chem. 263:1988;12948-12953.
75. Santoro S.A., Lawing W.J. Competition for related but nonidentical binding sites on the glycoprotein IIb-IIIa complex by peptides derived from platelet adhesive proteins. Cell. 48:1987;867-873.
76. Gulino D., Boudignon C., Zhang L., Concord E., Rabiet M.-J., Marguerie G. Ca2+-binding properties of the platelet IIb ligand-interacting domain. J Biol Chem. 267:1992;1001-1007.
77. Du X., Ginsberg M.H. Integrin alpha IIb beta 3 and platelet function. Thromb Haemost. 78:1997;96-100.
78. Baneres J.L., Roquet F., Green M., LeCalvez H., Parello J. The cation-binding domain from the alpha subunit of integrin alpha5 beta1 is a minimal domain for fibronectin recognition. J Biol Chem. 273:1998;24744-24753.
79. Hu D.D., White C.A., Panzer-Knodle S., Page J.D., Nicholson N., Smith J.W. A new model of dual interacting ligand binding sites on integrin alphaIIbbeta3. J Biol Chem. 274:1999;4633-4639.
80. Baldwin E.T., Sarver R.W., Bryant G.L., Curry K.A., Fairbanks M.B., Finzel B.C., Garlick R.L., Heinrikson R.L., Horton N.C., Kelley L.-L.C., et al. Cation binding to CD11b I domain and activation model assessment. Structure. 6:1998;923-935.
81. Tuckwell D.S., Humphries M.J. A structure prediction for the ligand-binding region of the integrin beta subunit: evidence for the presence of a von Willebrand factor A domain. FEBS Lett. 400:1997;297-303.
82. Cierniewski C.S., Haas T.A., Smith J.W., Plow E.F. Characterization of cation-binding sequences in the platelet integrin GPIIb-IIIa (alpha IIb beta 3) by terbium luminescence. Biochemistry. 33:1994;12238-12246.
83. Mehta R.J., Diefenbach B., Brown A., Cullen E., Jonczyk A., Gussow D., Luckenbach G.A., Goodman S.L. Transmembrane-truncated alphavbeta3 integrin retains high affinity for ligand binding: evidence for an 'inside-out' suppressor? Biochem J. 330:1998;861-869.
84. i alpha 1 beta 1 gamma 2. Cell. 83:1995;1047-1058.
85. Bork P., Doerks T., Springer T.A., Snel B. Domains in plexins: links to integrins and transcription factors. Trends Biochem Sci. 24:1999;261-263.
86. Downing A.K., Knott V., Werner J.M., Cardy C.M., Campbell I.D., Handford P.A. Solution structure of a pair of calcium-binding epidermal growth factor-like domains: implications for the Marfan syndrome and other genetic disorders. Cell. 85:1996;597-605.
87. Beglova N., Blacklow S.C., Takagi J., Springer T.A. Cysteine-rich module structure reveals a fulcrum for integrin rearrangement upon activation. Nat Struct Biol. 9:2002;282-287.
88. Tan S.M., Walters S.E., Mathew E.C., Robinson M.K., Drbal K., Shaw J.M., Law S.K. Defining the repeating elements in the cysteine-rich region (CRR) of the CD18 integrin beta 2 subunit. FEBS Lett. 505:2001;27-30.
89. Bode W., Engh R., Musil D., Thiele U., Huber R., Karshikov A., Brzin J., Kos J., Turk V. The 2.0 Å X-ray crystal structure of chicken egg white cystatin and its possible mode of interaction with cysteine proteinases. EMBO J. 7:1988;2593-2599.
90. Alonso J.L., Makram Essafi M., Xiong J.-P., Stehle T., Arnaout M.A. Does the integrin αA domain act as a ligand for its βA domain? Curr Biol. 12:2002;R340-R342. Using the information from the crystal structure of the αVβ3-RGD complex, the authors propose that active αA is a ligand for βA. The structural model shows that an invariant glutamic acid in the flexible carboxy-terminal linker at the base of αA, is seated at the βA MIDAS in active αA, where it forms a direct glutamic-acid-cation bond. Mutagenesis data show that this ligation is tolerated by a glutamic acid to aspartic acid but not by a glutamic acid to glutamine substitution. This ionic linkage may provide a physiologic internal lock that stabilises αA in the active state.
91. Binnerts M.E., van Kooyk Y., Edwards C.P., Champe M., Presta L., Bodary S.C., Figdor C.G., Berman P.W. Antibodies that selectively inhibit leukocyte function-associated antigen 1 binding to intercellular adhesion molecule-3 recognize a unique epitope within the CD11a I domain. J Biol Chem. 271:1996;9962-9968.
92. Huth J.R., Olejniczak E.T., Mendoza R., Liang H., Harris E.A., Lupher M.L. Jr, Wilson A.E., Fesik S.W., Staunton D.E. NMR and mutagenesis evidence for an I domain allosteric site that regulates lymphocyte function-associated antigen 1 ligand binding. Proc Natl Acad Sci USA. 97:2000;5231-5236.
93. Dechantsreiter M.A., Planker E., Matha B., Lohof E., Holzemann G., Jonczyk A., Goodman S.L., Kessler H. N-methylated cyclic RGD peptides as highly active and selective alpha(V)beta(3) integrin antagonists. J Med Chem. 42:1999;3033-3040.
94. Redick S.D., Settles D.L., Briscoe G., Erickson H.P. Defining fibronectin's cell adhesion synergy site by site-directed mutagenesis. J Cell Biol. 149:2000;521-527.
95. Copie V., Tomita Y., Akiyama S.K., Aota S., Yamada K.M., Venable R.M., Pastor R.W., Krueger S., Torchia D.A. Solution structure and dynamics of linked cell attachment modules of mouse fibronectin containing the RGD and synergy regions: comparison with the human fibronectin crystal structure. J Mol Biol. 277:1998;663-682.
96. Plow E.F., Ginsberg M.H. Specific and saturable binding of plasma fibronectin to thrombin-stimulated human platelets. J Biol Chem. 256:1981;9477-9482.
97. Kauf A.C., Hough S.M., Bowditch R.D. Recognition of fibronectin by the platelet integrin alpha IIb beta 3 involves an extended interface with multiple electrostatic interactions. Biochemistry. 40:2001;9159-9166.
98. D'Souza S.E., Ginsberg M.H., Burke T.A., Plow E.F. The ligand binding site of the platelet integrin receptor GPIIb-IIIa is proximal to the second calcium binding domain of its alpha subunit. J Biol Chem. 265:1990;3440-3446.
99. Scarborough R.M., Naughton M.A., Teng W., Rose J.W., Phillips D.R., Nannizzi L., Arfsten A., Campbell A.M., Charo I.F. Design of potent and specific integrin antagonists. Peptide antagonists with high specificity for glycoprotein IIb-IIIa. J Biol Chem. 268:1993;1066-1073.
100. Kamata T., Irie A., Tokuhira M., Takada Y. Critical residues of integrin alphaIIb subunit for binding of alphaIIbbeta3 (glycoprotein IIb-IIIa) to fibrinogen and ligand-mimetic antibodies (PAC-1, OP-G2, and LJ-CP3). J Biol Chem. 271:1996;18610-18615.
101. Basani R.B., French D.L., Vilaire G., Brown D.L., Chen F., Coller B.S., Derrick J.M., Gartner T.K., Bennett J.S., Poncz M. A naturally occurring mutation near the amino terminus of alphaIIb defines a new region involved in ligand binding to alphaIIbbeta3. Blood. 95:2000;180-188.
102. Tozer E.C., Baker E.K., Ginsberg M.H., Loftus J.C. A mutation in the alpha subunit of the platelet integrin alphaIIbbeta3 identifies a novel region important for ligand binding. Blood. 93:1999;918-924.
103. Puzon-McLaughlin W., Kamata T., Takada Y. Multiple discontinuous ligand-mimetic antibody binding sites define a ligand binding pocket in integrin alpha(IIb)beta(3). J Biol Chem. 275:2000;7795-7802.
104. Cierniewski C.S., Byzova T., Papierak M., Haas T.A., Niewiarowska J., Zhang L., Cieslak M., Plow E.F. Peptide ligands can bind to distinct sites in integrin alphaIIbbeta3 and elicit different functional responses. J Biol Chem. 274:1999;16923-16932.
105. Ware S., Donahue J.P., Hawiger J., Anderson W.F. Structure of the fibrinogen gamma-chain integrin binding and factor XIIIa cross-linking sites obtained through carrier protein driven crystallization. Protein Sci. 8:1999;2663-2671.
106. Yang Z., Mochalkin I., Veerapandian L., Riley M., Doolittle R.F. Crystal structure of native chicken fibrinogen at 5.5-Å resolution. Proc Natl Acad Sci USA. 97:2000;3907-3912.
107. Wang J.H., Pepinsky R.B., Stehle T., Liu J.H., Karpusas M., Browning B., Osborn L. The crystal structure of an N-terminal two-domain fragment of vascular cell adhesion molecule 1 (VCAM-1): a cyclic peptide based on the domain 1 C-D loop can inhibit VCAM-1-alpha 4 integrin interaction. Proc Natl Acad Sci USA. 92:1995;5714-5718.
108. Komoriya A., Green L.J., Mervic M., Yamada S.S., Yamada K.M., Humphries M.J. The minimal essential sequence for a major cell type-specific adhesion site (CS1) within the alternatively spliced type III connecting segment domain of fibronectin is leucine-aspartic acid-valine. J Biol Chem. 266:1991;15075-15079.
109. Kamata T., Puzon W., Takada Y. Identification of putative ligand-binding sites of the integrin α4β1. Biochem J. 305:1995;945-951.
110. Irie A., Kamata T., Takada Y. Multiple loop structures critical for ligand binding of the integrin alpha4 subunit in the upper face of the beta-propeller mode 1. Proc Natl Acad Sci USA. 94:1997;7198-7203.
111. Muller B., Zerwes H.G., Tangemann K., Peter J., Engel J. Two-step binding mechanism of fibrinogen to alpha IIb beta 3 integrin reconstituted into planar lipid bilayers. J Biol Chem. 268:1993;6800-6808.
112. Huber W., Hurst J., Schlatter D., Barner R., Hubscher J., Kouns W.C., Steiner B. Determination of kinetic constants for the interaction between the platelet glycoprotein IIb-IIIa and fibrinogen by means of surface plasmon resonance. Eur J Biochem. 227:1995;647-656.